A Study of Gaboxadol in Primary Insomnia

An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)

NCT00102154 ·Status: WITHDRAWN ·Phase: PHASE3

Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)

NCT00102167 ·Status: COMPLETED ·Phase: PHASE3

MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)

NCT00266344 ·Status: COMPLETED ·Phase: PHASE2

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

NCT00094666 ·Status: TERMINATED ·Phase: PHASE3

Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)

NCT00095043 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

NCT00095069 ·Status: COMPLETED ·Phase: PHASE3

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

NCT00266357 ·Status: TERMINATED ·Phase: PHASE2

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

NCT00280423 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

NCT00103818 ·Status: COMPLETED ·Phase: PHASE3

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

NCT00280436 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary Insomnia

NCT00426816 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness

NCT00666575 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia

NCT00354809 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity

NCT02464046 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

NCT00569972 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of EVT 201 to Treat Insomnia

NCT00380003 ·Status: COMPLETED ·Phase: PHASE2

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

NCT00551148 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274

NCT02852395 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

NCT00784875 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3

Treatments for Insomnia in Patients With Parkinson's Disease

NCT01489982 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Study of LY2624803 in Participants With Transient Insomnia

NCT01779830 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

NCT02841709 ·Status: COMPLETED ·Phase: PHASE2

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

NCT00420810 ·Status: TERMINATED ·Phase: PHASE3

Characteristics of Sleep Patterns in Young Adults With and Without Insomnia

NCT00177216 ·Status: COMPLETED ·Phase: PHASE4